Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.3.2 in place of Revision: v3.3.1. This is a minor UI label change and does not affect study data or functionality.
    Difference
    0.1%
    Check dated 2025-12-01T16:25:48.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The record history now includes an added Revision v3.3.1 entry and the v3.2.0 entry has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:10:24.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The notice about government funding and operating status at the top of the page was removed, with no impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:20:13.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No new content was added or removed; the page only displays the existing Record History with version dates.
    Difference
    0.1%
    Check dated 2025-11-03T00:57:17.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    13%
    Check dated 2025-10-05T09:11:16.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version bump: from v3.0.2 to v3.1.0, updating the page's revision metadata.
    Difference
    0.3%
    Check dated 2025-09-28T03:06:24.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.